Burleson commented in a research report on Thursday that the selloff in Proto Labs' stock represents a "solid entry point" given its strong business model and an attractive valuation.
Business Model
According to Burleson, Proto Labs' proprietary software makes it a leader in the space, and there is unlikely to be a challenger to its "leading position" in quick turn CNC machining and injecting molding services.
The analyst added that Proto Labs' "strongly ramping additive" manufacturing business represents a tailwind to gross margins as its recently acquired facilities in Europe increases its capacity utilization over the remainder of 2016.
In addition, Proto Labs is in a strong position to grow its share of unique product developers through an improved marketing effort.
Valuation
Burleson continued that Proto Labs' exposure to customer R&D activity has made it a "lagging indicator of industrial demand." In fact, the company hasn't seen any macro-related weakness until the first quarter of this year compared to some of its peers that saw weakness as early as mid-2015.
As the macro environment improves over time, the company at the very least can maintain its market share, which justifies "at least" a valuation of 15x EV/EBITDA on 2017 estimates. By comparison, the analyst pointed out that the range prior to the macro-related slowdown has been roughly 15x to 20x.
Shares remain Buy rated with an unchanged price target of $65, which implies a 14.6x multiple to the analyst's 2017E EBITDA.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.